Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page

Q3 2023 Substance Use Disorder Services

Skip to the end of the Expertise Menu

Q3 2023 Substance Use Disorder Services

The Substance Use Disorder (SUD) space has seen fairly steep declines in deal activity. Restrictive lending markets and inflationary wage pressures have been the primary hurdles to growth in the sector, with traditional consolidators like Acadia and UHS instead turning to de novo strategies, such as site development and joint-venture arrangements, to pursue growth.

Notable Q3-23 transactions included two joint-ventures with Acadia Healthcare and regional health systems. Methodist and Solution will leverage Acadia’s behavioral health expertise while Acadia is looking to capitalize on their partners’ local payor relationships and referral volume to build large behavioral health facilities to improve care access in their regions.

To print and download the Substance Use Disorder Services Update report, please click below…

[holo_button icon=”/wp-content/uploads/2023/10/Q3-23-Substance-Use-Disorder.pdf”” color=”#003561″ target=”blank”]PRINT/DOWNLOAD[/holo_button]